Is this the market’s ultimate bargain corner?
Publisher |
The Australian
Media Type |
audio
Categories Via RSS |
Business
Investing
Society & Culture
Technology
Publication Date |
May 12, 2022
Episode Duration |
00:44:03

Tim Boreham, Stockhead's small caps correspondent joins The Australian's Wealth Editor James Kirby on this week's show. They discuss how Biotech gets hit hardest of all, one reason this sector may recover first and three ASX biotech stocks for you to consider.

 

See omnystudio.com/listener for privacy information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review